Tofacitinib tablets bulk supplier for pharma manufacturers

Tofacitinib Tablets 5 mg, 10 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 5 mg, 10 mg

Reference Brands: Xeljanz(US & EU)

Category: Arthritis

Tofacitinib inhibits Janus kinase (JAK) enzymes, blocking cytokine signaling involved in inflammation. It effectively reduces symptoms and disease progression in rheumatoid arthritis. Benefits include rapid symptom relief, improved joint function, and enhanced quality of life, with an oral formulation providing convenient administration for long-term autoimmune disease management.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Tofacitinib tablets are approved in the EU and US for rheumatoid arthritis and other autoimmune diseases. In the EU, Pfizer’s Xeljanz is regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing quality. In the US, FDA approval is based on comprehensive clinical data and biosimilarity assessments. Both regions require detailed dossiers for initial approval and ongoing pharmacovigilance. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We support efficient market access for tofacitinib tablets, ensuring adherence to European and American standards for safe, effective treatment of autoimmune conditions, helping you navigate complex regulatory landscapes seamlessly.

Tofacitinib Tablets — third party manufacturing & bulk supply

Tofacitinib Tablets 5 mg, 10 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Tofacitinib Tablets is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Tofacitinib Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Tofacitinib Tablets →

Back to Listing

Frequently Asked Questions

Tofacitinib tablets is listed as Tablets in 5 mg, 10 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Tofacitinib tablets is referenced against Xeljanz(US & EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.